SEC61A1 and Miyoshi myopathy: Inhibiting Sec61 with cotransin increased the surface expression of BCMA by MM cell lines, resulting in enhanced efficacy a BCMA‐targeting antibody–drug conjugate (Ramkumar et al, 2020).